Literature DB >> 1693473

Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.

M M Silver1, S A Hearn, J C Walton, L A Lines, V M Walley.   

Abstract

By quantitative immunoelectron microscopy using protein A-gold, the authors compared the content and distribution of immunoglobulin light chain (LC) antigens in glomeruli from 11 cases of renal amyloidosis with that in two cases of kappa LC glomerulopathy and two cases of diabetic glomerulosclerosis. In a supplementary study and using a similar immunogold technique, the authors identified amyloid A in deparaffinized renal tissue from three of the 11 cases of renal amyloidosis. Each patient had similar clinical manifestations (chronic renal failure with proteinuria) and similar glomerular morphology (thickened glomerular basement membranes and nodular expansion of the mesangium). In 12 cases (10 amyloid, 2 kappa LC), immunoelectron microscopy localized LC antigens over the glomerular deposits and allowed indirect tissue quantitation of each LC antigen to the various cellular and interstitial compartments. In 6 of the 11 cases of renal amyloidosis, the amyloid labeled only for lambda, and in one, only for kappa. In one patient with Waldenström's macroglobulinemia, who had a biclonal gammopathy, both LC were identified in the amyloid. In two cases, both of whom had a history of chronic suppurative lung disease, both LC antigens as well as amyloid A were localized to the amyloid fibrils. In only one case, in which glomerular amyloid labeled for amyloid A, the amyloid did not label for either LC. Whereas lambda LC-derived fibrils often appeared as spicules in the glomerular subepithelial space, other amyloid deposits usually accumulated in the subendothelial zone and did not form spicules. The epimembranous location of spicules suggested that the amyloid precursor protein transformed into amyloid fibrils after filtration into the urinary space. Presence of epimembranous spicules may explain the more severe proteinuric renal failure and the more rapid progression to glomerulosclerosis described in primary amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693473      PMCID: PMC1877439     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  THE SITE OF FORMATION AND ULTRASTRUCTURE OF AMYLOID.

Authors:  B GUEFT; J J GHIDONI
Journal:  Am J Pathol       Date:  1963-11       Impact factor: 4.307

2.  Experimental amyloidosis. I. Light and electron microscopic observation of spleen and lymph nodes.

Authors:  W A HEEFNER; G D SORENSON
Journal:  Lab Invest       Date:  1962-08       Impact factor: 5.662

3.  Immunohistochemical characterization of renal amyloidosis.

Authors:  L H Noel; D Droz; D Ganeval
Journal:  Am J Clin Pathol       Date:  1987-06       Impact factor: 2.493

4.  Characterization of tissue amyloid by immunofluorescence microscopy.

Authors:  G R Gallo; H D Feiner; J V Chuba; D Beneck; P Marion; D H Cohen
Journal:  Clin Immunol Immunopathol       Date:  1986-06

5.  Systemic kappa light chain deposition and amyloidosis in multiple myeloma: novel morphological observations.

Authors:  C J Kirkpatrick; A Curry; J Galle; I Melzner
Journal:  Histopathology       Date:  1986-10       Impact factor: 5.087

6.  Renal and systemic kappa light chain deposits and their plasma cell origin identified by immunoelectron microscopy.

Authors:  M M Silver; S A Hearn; S Ritchie; R P Slinger; J A Sholdice; P S Cordy; A B Hodsman
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

7.  Fine structure of the glomerulus in human and experimental renal amyloidosis.

Authors:  T Shirahama; A S Cohen
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

8.  Ultrastructural immunolabeling in the diagnosis of light-chain-related renal disease.

Authors:  G A Herrera; R Paul; E A Turbat-Herrera; J Work; G Viale; P dell'Orto; R L Lott; R Colombi; C W Old; R H Lyerly
Journal:  Pathol Immunopathol Res       Date:  1986

9.  Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as beta 2-microglobulin.

Authors:  T Shirahama; M Skinner; A S Cohen; F Gejyo; M Arakawa; M Suzuki; Y Hirasawa
Journal:  Lab Invest       Date:  1985-12       Impact factor: 5.662

10.  Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis.

Authors:  L M Looi; E Sumithran
Journal:  Hum Pathol       Date:  1988-06       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.